Vivoryon Therapeutics NV (VVY) — Financial Flexibility Index
Vivoryon Therapeutics NV (VVY) has a Financial Flexibility Index of -1.42x as of December 2025. Free cash flow of €-3.96 Million (operating CF €-3.96 Million minus capex €2.00K) represents -1% of total liabilities (€2.79 Million). Check Vivoryon Therapeutics NV (VVY) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Vivoryon Therapeutics NV Financial Flexibility Index (2011–2025)
Historical Financial Flexibility Index trend for Vivoryon Therapeutics NV across 15 annual periods. See Vivoryon Therapeutics NV (VVY) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Vivoryon Therapeutics NV (2011–2025)
Year-by-year free cash flow to debt coverage for Vivoryon Therapeutics NV. For the full company profile including market capitalisation, see VVY stock market capitalisation.
| Year | Flexibility Index | Free Cash Flow (EUR) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.03x | €-8.45 Million | €-8.46 Million | €2.79 Million | ▲ +46.3% |
| 2024 | -5.63x | €-19.17 Million | €-19.17 Million | €3.40 Million | ▼ -21.8% |
| 2023 | -4.62x | €-21.03 Million | €-21.54 Million | €4.55 Million | ▼ -3.4% |
| 2022 | -4.47x | €-21.78 Million | €-21.79 Million | €4.87 Million | ▼ -217.0% |
| 2021 | -1.41x | €-11.23 Million | €-11.26 Million | €7.96 Million | ▲ +62.8% |
| 2020 | -3.79x | €-13.37 Million | €-14.01 Million | €3.53 Million | ▼ -4.7% |
| 2019 | -3.62x | €-11.56 Million | €-11.61 Million | €3.20 Million | ▼ -46.1% |
| 2018 | -2.48x | €-6.98K | €-6.99K | €2.82K | ▲ +62.4% |
| 2017 | -6.59x | €-12.11K | €-12.12K | €1.84K | ▼ -197.7% |
| 2016 | -2.21x | €-13.25K | €-13.26K | €5.99K | ▼ -4.4% |
| 2015 | -2.12x | €-12.14K | €-12.15K | €5.73K | ▼ -10.2% |
| 2014 | -1.92x | €-10.59K | €-10.59K | €5.51K | ▼ -140.7% |
| 2013 | -0.80x | €-8.46 Million | €-8.53 Million | €10.60 Million | ▲ +68.9% |
| 2012 | -2.57x | €-11.92 Million | €-12.04 Million | €4.64 Million | ▲ +25.1% |
| 2011 | -3.43x | €-14.22 Million | €-14.32 Million | €4.15 Million | — |